drugset / Trial / NCT04072640

Three Induction Treatments on Cryptococcal Meningitis

NCT04072640

RandomizedParallel-groupSingle-blindTreatment

Summary

Three induction treatment strategies \[ voriconazole +5FC vs. amphotericin deoxycholate (0.4-0.5 mg/kg/d)+5FC vs. amphotericin deoxycholate (0.7-1.0 mg/kg/d)+5FC \] for HIV-infected patients with cryptococcal meningitis were compared.

Timeline

Start
2021-01-25
Primary completion
2022-07-31
Completion
2022-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Voriconazole Small molecule 200 mg Intravenous
Subject amphotericin B deoxycholate Unknown 0.4 mg/kg
Subject amphotericin B deoxycholate Unknown 0.7 mg/kg